Soluble mesothelin, megakaryocyte potentiating factor, and osteopontin as markers of patient response and outcome in mesothelioma.

Hollevoet, Kevin;Nackaerts, Kristiaan;Gosselin, Robert;De Wever, Walter;van Meerbeeck, Jan P;et.al.
(2011) Journal of Thoracic Oncology — Vol. 6, n° 11, p. 1930-1937 (2011)

Files

No attached file found for this publication.

Details

Authors
  • Hollevoet, Kevin
    Author
  • Nackaerts, Kristiaan
    Author
  • Gosselin, Robert
    Author
  • De Wever, Walter
    Author
  • Legrand, CatherineUCLouvain
    Author
  • van Meerbeeck, Jan P
    Author
Show more
Abstract
SM and MPF levels were more closely associated with disease course than OPN and might prove useful in monitoring patient response in mesothelioma. Baseline OPN levels were an independent negative predictor of survival. These promising results require further validation.
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Hollevoet, K., Nackaerts, K., Gosselin, R., De Wever, W., Bosquée, L., De Vuyst, P., Germonpré, P., Kellen, E., Legrand, C., Kishi, Y., Delanghe, J. R., & van Meerbeeck, J. P. (2011). Soluble mesothelin, megakaryocyte potentiating factor, and osteopontin as markers of patient response and outcome in mesothelioma. Journal of Thoracic Oncology, 6(11), 1930-1937. https://doi.org/10.1097/JTO.0b013e3182272294 (Original work published 2011)